JIP
ITCI
Jaffetilchin Investment Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,972
| Closed | -$392K | – | 467 |
|
|
2025
Q1 | $392K | Sell |
2,972
-2,224
| -43% | -$293K | 0.03% | 276 |
|
|
2024
Q4 | $434K | Hold |
5,196
| – | – | 0.03% | 252 |
|
|
2024
Q3 | $380K | Hold |
5,196
| – | – | 0.03% | 255 |
|
|
2024
Q2 | $356K | Sell |
5,196
-250
| -5% | -$17.1K | 0.03% | 263 |
|
|
2024
Q1 | $377K | Sell |
5,446
-100
| -2% | -$6.92K | 0.03% | 253 |
|
|
2023
Q4 | $397K | Sell |
5,546
-800
| -13% | -$57.3K | 0.04% | 245 |
|
|
2023
Q3 | $331K | Sell |
6,346
-185
| -3% | -$9.64K | 0.04% | 250 |
|
|
2023
Q2 | $414K | Sell |
6,531
-190
| -3% | -$12K | 0.04% | 225 |
|
|
2023
Q1 | $364K | Buy |
6,721
+185
| +3% | +$10K | 0.04% | 251 |
|
|
2022
Q4 | $346K | Sell |
6,536
-23,700
| -78% | -$1.25M | 0.04% | 247 |
|
|
2022
Q3 | $1.41M | Sell |
30,236
-467
| -2% | -$21.7K | 0.18% | 79 |
|
|
2022
Q2 | $1.75M | Sell |
30,703
-638
| -2% | -$36.4K | 0.21% | 85 |
|
|
2022
Q1 | $1.73M | Sell |
31,341
-864
| -3% | -$47.7K | 0.2% | 75 |
|
|
2021
Q4 | $1.69M | Sell |
32,205
-11,575
| -26% | -$606K | 0.16% | 93 |
|
|
2021
Q3 | $1.63M | Sell |
43,780
-47,158
| -52% | -$1.76M | 0.17% | 90 |
|
|
2021
Q2 | $3.32M | Buy |
90,938
+47,197
| +108% | +$1.72M | 0.23% | 82 |
|
|
2021
Q1 | $1.48M | Sell |
43,741
-188
| -0.4% | -$6.38K | 0.17% | 108 |
|
|
2020
Q4 | $1.4M | Buy |
+43,929
| New | +$1.4M | 0.2% | 84 |
|